John Yianni is a partner at Earlybird. John has over 25 years of experience in the medical device industry. John was the founder and board member of Reverse Medical Corp, which was sold to Covidien in 2014. John was also the chairman and CEO of Thermocore Medical Ltd, where they developed a device for detecting inflamed plaque in coronary arteries.
John Yianni attended Battersea Grammar School before going on to The University of Salford, where they earned their PhD in Biophysics.
Their manager is Roland Manger, Co-Founder & Partner. Some of their coworkers include Susann Götz - Executive Assistant, Dan Lupu - Partner, and Laurent Le Portz - Venture Partner.
Current role